Form D · Pharmaceuticals
Akava Therapeutics Inc.
Winnetka, IL · CIK 0001966649
Offering snapshot reported Feb 19, 2026 · SEC filing
- Reported sold
- Yet to sell Offering amount: $15M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 19, 2026 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 21, 2025 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Apr 23, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Mar 3, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-573943
Source: Form D, filed Feb 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brendan Mac Millan | Director |
| Joseph Nolan | Director |
| Charles Polsky | Director, Executive |
| Philip Silverman | Director, Executive |
| Richard Silverman | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
755 Sheridan Road
Winnetka, IL, 60093
Phone: (847) 494-7434
Winnetka, IL, 60093
Phone: (847) 494-7434